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Background: Aboriginal populations living in Canada’s northern regions are exposed to a number of persistent
organic pollutants through their traditional diet which includes substantial amounts of predator fish species.
Exposure to dioxin-like compounds (DLCs) can cause a variety of toxic effects including adverse effects on bone
tissue. This descriptive cross-sectional study was conducted to investigate the relationship between plasma
concentrations of DLCs and bone quality parameters in Cree women of Eastern James Bay (Canada).
Methods: Two hundred and forty-nine Cree women from seven communities in Eastern James Bay (Canada), aged
35 to 74 years old, participated in the study. In order to determine the total DLC concentration in plasma samples
of participants, we measured the aryl hydrocarbon receptor-mediated transcriptional activity elicited by plasma
sample extracts using a luciferase reporter gene assay. Plasma concentrations of mono-ortho-substituted dioxin-like
polychlorinated biphenyls (DL-PCBs) 105, 118 and 156 were measured by gas chromatography–mass spectrometry.
Bone quality parameters (speed of sound, m/s; broadband ultrasound attenuation, dB/MHz; stiffness index, %) were
assessed by quantitative ultrasound at the right calcaneus with the Achilles InSight system. Several factors known to
be associated with osteoporosis were documented by questionnaire. Multiple linear regression models were
constructed for the three ultrasound parameters.
Results: DL-PCBs 105 and 118 concentrations, but not the global DLC concentration, were inversely associated with
the stiffness index, even after adjusting for several confounding factors. The stiffness index (log) decreased by −0.22%
(p=0.0414) and −0.04% (p=0.0483) with an increase of one μg/L in plasma concentrations of DL-PCB 105 and DL-PCB 118,
respectively. Other factors, including age, height, smoking status, menopausal status and the percentage of omega-6
polyunsaturated fatty acids (PUFAs) in erythrocyte membranes were negatively associated with one of the ultrasound
parameters, while the percentage of omega-3 PUFAs in these membranes and levels of physical activity and education
were positively associated with them.
Conclusions: Our results show that an increase in plasma concentrations of DL-PCBs 105 and 118 was negatively
associated with stiffness index, a measure of bone quality/strength, in women of this population. In addition to
environmental contaminants, future studies should also consider PUFA intake as a factor influencing bone quality.
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Osteoporosis is “a systemic skeletal disease characterized
by low bone mass and micro-architectural deterioration of
bone tissue, with a consequent increase in bone fragility
and susceptibility to fractures” [1]. It is a multifactorial
polygenic disease in which genetic determinants are mo-
dulated by hormonal, environmental, and nutritional fac-
tors [2], is asymptomatic and progress silently with age
[3]. Eighty one percent of all fractures in women aged
50 years and older can be attributed to osteoporosis [4].
Osteoporotic fractures, such as those of the hip, spine and
wrist, often appear in older people following minor
trauma. Hip fractures lead to rehabilitation problems and
greatly decrease the quality of life [5,6].
Very little information is available on bone mineral
density (BMD), fracture risk and their determinants
among Canada’s First Nations people. The only existing
publications focus on Manitoba’s Aboriginal population
[7-12]. Retrospective studies using administrative health
data have reported that members of First Nations in
Manitoba had significantly higher osteoporotic fracture
rates than non-Aboriginals [8,9]. Factors such as low so-
cioeconomic status, diabetes [8] or the number of comor-
bidities and alcohol and drug use [9] were associated with
higher fracture rates in these populations. Low calcium
and vitamin D intake among Aboriginals, particularly
older women [13], may also play a role.
Moreover, Aboriginal populations living in the northern
regions of the globe are exposed to persistent organic pol-
lutants through their traditional diet [14]. These include
dioxin-like compounds (DLCs), similar in structure to
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which are
lipophilic, resistant to biodegradation and therefore bio-
accumulate and bioamplify in aquatic food chains, where
Aboriginals obtain part of their diet [15]. Yet the findings
of in vitro studies [16] and experimental studies on rats
[17-19] show that TCDD, the most toxic compound in the
DLC family, has multiple effects on bone tissue, resulting
in increased bone fragility. Few human studies have fo-
cused on the relationship between exposure to DLCs and
bone quality/strength. Furthermore, while populations are
exposed to a complex mixture of DLCs, only the plasma
concentrations of certain dioxin-like PCBs (DL-PCBs)
have been measured in participants in order to study the
relationship between their concentrations and BMD or
quantitative ultrasound (QUS) parameters [20-22].
The objective of this study was to investigate the rela-
tionship between plasma concentrations of DLCs or cer-
tain dioxin-like mono-ortho-substituted PCBs (DL-PCBs
105, 118 and 156) and calcaneal QUS parameters in Cree
women of Eastern James Bay (Canada). Ultrasound bone
measurement is a method used to assess bone strength
that provides information that is complementary to
BMD [23]. Recent studies demonstrate that QUS at thecalcaneus can predict fractures as effectively as DXA in
postmenopausal women and men over the age of 65
[24]. Values of QUS parameters are generally lower in
osteoporotic patients than in healthy subjects [25]. This
technique has several advantages: it is simple, fast, non-
invasive, radiation-free and inexpensive. Furthermore,
ultrasound bone measurement devices are portable and
easy to use in remote, isolated regions, such as those
inhabited by northern Aboriginal communities, where
measurement of BMD cannot be performed by dual-
energy x-ray absorptiometry (DXA).Methods
Population
An environmental and health survey, entitled “Nituu-
chischaayihtitaau Aschii. Multi-community Environment-
and Health Longitudinal Study in Eeyou Istchee”, was
conducted from summer 2005 to summer 2009 in seven
Cree communities located north of the 49th parallel north,
in the Eastern James Bay region of the province of Quebec
(Canada). The objective of this study was to investigate
the health of these Aboriginal populations and the risk
factors affecting them [26,27].
Participants, stratified by age (0–7 years; 8–14 years;
15–39 years; ≥40 years) and gender, were selected using
simple random sampling, without replacement, from the
Beneficiary List in each community to create lists of
potential participants to be contacted by recruiters. A
weighting was attributed to each stratum to ensure that
inferences could be drawn about the population. An ini-
tial list of subjects to be contacted was drawn up and all
these people were contacted and asked to participate in
the study. If they refused, a second list of participants
was randomly created and recruitment continued in
order to ensure the required number of subjects in each
age group [28]. Owing to the low response rate (53.5%)
in the first community visited, a correction to the prede-
fined samples had to be taken into account in order to
maintain the desired statistical power; the sample size in
subsequent communities was therefore increased [29].
The total response rate of females (all age categories com-
bined) varied between 34.4% and 70.9% depending on the
community (Centre de Recherche du CHU de Québec,
unpublished data). With respect to the non-participants,
some could not be reached; some were undecided and
withdrew, while others refused to participate. Others were
excluded (unknown in the community, non-Cree, preg-
nant, disabled) [28,29].
All participants (aged 8 years and over) completed a
series of questionnaires in Eeyou Ayimuwin or English
and administered by the research staff or interviewers
(selected in local communities and provided with appro-
priate training) [30,31]. They then underwent a clinical
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measurements collected by research nurses.
All women aged 35 to 74 years who participated in the
clinical examination were eligible for the calcaneal ultra-
sound measurement. A total of 254 women had QUS
parameters measured. The volume of plasma collected
from 249 women was sufficient to allow testing for
DLCs and DL-PCBs.
Bone measurements
Two QUS parameters were measured at the right calca-
neus of Cree women using a portable Achilles Insight
system (GE Healthcare Lunar, Madison, WI, USA): 1)
speed of sound (SOS, m/s) and 2) broadband ultrasound
attenuation (BUA, dB/MHz) [32]. The Stiffness Index
(SI, %) was automatically calculated by the system from
the two parameters using the manufacturer’s formula
[SI% = (0.67*BUA) + (0.28*SOS) – 420]. A research
nurse inspected and calibrated the system’s membranes
daily using the phantom provided by the manufacturer.
In vitro accuracy was assessed by taking a number of re-
peated measurements with the manufacturer’s phantom:
the mean coefficients of variation (CVs) recorded for the
SOS parameter ranged from 0.05 to 0.12% depending on
the community.
Anthropometric measurements
Body composition was measured using a bioelectric
impedance analyzer (Tanita Corporation of America,
IL, USA). Weight, lean body mass and body fat (kg),
height, sitting height, waist and hip circumference (cm)




Plasma samples were tested for DLCs and DL-PCBs at
INSPQ’s Toxicology Laboratory (Quebec City, Canada).
The luciferase reporter gene cell assay described by
Medehouenou et al. [33] was used to measure AhR-
mediated transcriptional activity elicited by plasma ex-
tracts and provide an integrated measure of DLCs. The
limit of detection (LOD) was 30 pg TCDD-equivalents
(EQ)/L. For quality control purposes, we used human
plasma spiked with TCDD to obtain a concentration of
322 pg/L. The mean concentration of this sample tested
22 times was 361 pg TCDD-EQ/L (bias=12.1%) and the
CV was 14%.
DL-PCBs (DL-PCB 105: 2,3,3’,4,4’-pentachlorobiphenyl;
DL-PCB 118: 2,3’4,4’,5-pentachlorobiphenyl and DL-PCB
156: 2,3,3’,4,4’,5-hexachlorobiphenyl) were measured by
gas chromatography–mass spectrometry (GC-MS) as
described extensively in the project reports [34,35]. For
samples from the first Cree community investigated, aliquid-liquid extraction was used followed by separation
and quantification of PCB congeners by GC-MS using
an Agilent 6890 Network GC system (Wilmington, DE,
USA), fitted with an Agilent 7683 series automatic liquid
sampler and an Agilent 5973 Network mass spectrom-
eter. The recovery rate for the three DL-PCB congeners
was over 90%. Coefficients of variation of 5.9%, 4.2% and
11.5% were obtained for DL-PCBs 105, 118 and 156 con-
geners respectively following repeated measures of stand-
ard reference material (SRM) 1589 (National Institute of
Standards and Technology, Gaithersburg, MD, USA). The
limit of detection for the three DL-PCBs was 0.02 μg/L
[34]. For samples from the six other Cree communities
investigated, a solid-phase extraction was used followed by
GC-MS analysis with the same instrumentation as
described above. Coefficients of variation of 7.4%, 7.7%
and 9.7% were obtained for the three DL-PCB 105, 118
and 156 congeners respectively, following repeated mea-
sures of SRM 1589; the detection limit was 0.01 μg/L [35].
Lipids
Concentrations of total lipids in plasma samples were
calculated using Phillips et al.’s formula [36]: [Total
lipids (g/L) = (0.878*cholesterol mmol/L) + (0.885*triglyc-
erides mmol/L) + 0.623]. Total cholesterol and triglyceride
concentrations were determined by standard enzymatic
methods. For the total cholesterol analysis, CVs of 1.5%
and 1.3% were obtained for reference samples containing
2.87 and 6.67 mmol/L respectively. For the triglycerides
analysis, CVs of 2.0% and 1.6% were noted for reference
samples with concentrations of 1.07 and 2.32 mmol/L
respectively [35].
Levels of omega-3 and omega-6 PUFAs were measured
in erythrocyte membranes by liquid gas chromatography
with flame ionisation detection at the Centre de
Recherche sur les Maladies Lipidiques, CHU de Québec
as previously described [34]. Omega-3 PUFAs refer to
the following fatty acids: α-linolenic acid (C18:3n-3) +
docosapentaenoic acid (C22:5n-3) + docosahexaenoic
acid (C22:6n-3) + eicosapentaenoic acid (C20:5n-3) +
(C18:4n-3) + (C20:3n-3) + (C20:4n-3). Omega-6 PUFAs
refer to the following fatty acids: linoleic acid (C18:2n-6) +
arachidonic acid (C20:4n-6) + (C18:3n-6) + (C20:2n-6) +
(C20:3n-6) + (C22:2n-6) + (C22:4n-6) + (C22:5n-6).
Apolipoprotein B (Apo B) was measured by nephe-
lometry using a BN ProSpec station (Dade Behring,
Mississauga, ON). Control levels of 0.46 and 1.44 g/L
for Apo B showed interassay CVs of 3.2% and 1.8% [34].
Metals/metalloids
Blood mercury levels (nmol/L) were measured by cold
vapour atomic absorption spectrometry (Pharmacia) [34].
Cadmium (nmol/L), selenium (μmol/L) and lead (μmol/L)
were measured by inductively coupled plasma mass
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in ammonium hydroxide and the metals converted to
their elemental form by aspirating the sample into
argon plasma before being identified and quantified by
mass spectrometry. The samples were analysed using a
Perkin Elmer Sciex Elan 6000 ICP-MS instrument). The
LODs were 0.04 nmol/L for cadmium, 0.001 μmol/L for
lead, 0.49 nmol/L for mercury and 0.09 μmol/L for se-
lenium [35].
Other analyses
Glucose was measured by a hexokinase enzymatic assay
employing the Roche Modular system. Interassay CVs
were 1.6% and 1.4% for glucose at control values of 4.74
and 15.66 mmol/L respectively [35]. Alpha-tocopherol
(vitamin E) was determined using a Waters high-pressure
liquid chromatography system (Lachine, QC) equipped
with an autosampler, a reverse phase column (Nucleosil
ODS1) and a UV detector [35]. Serum levels of 25-
hydroxyvitamin D (25OHD) were measured in the Bio-
chemistry Laboratory at Montreal’s Hôpital St-Luc
(CHUM) by a procedure that includes extraction and quan-
tification by competitive radioimmunoassay using the IDS
radioimmunoassay kit (Medicorp Inc., Montreal, QC) [35].
Questionnaires
Questionnaires were used to collect information about
participants’ socio-demographic characteristics (date and
place of birth; level of education: none or primary school/
secondary and higher), their lifestyle habits (tobacco use:
yes/no; use of calcium and vitamin D supplements in the
last 12 months: yes/no; physical activity: active/inactive;
alcohol intake in the last 12 months: yes/no; milk con-
sumption in the last month: yes/no), their gynaecological
history (menopausal status: menopausal/non-menopausal;
parity: yes/no; number of children; use of hormonal con-
traceptives: yes/no; use of hormone replacement therapy,
HRT: yes/no) and their personal fracture history (yes/no).
Women were considered menopausal if they had had no
menstrual periods for one year before recruitment. So-
dium intake (≤ 2300 mg vs > 2300 mg/day) was compiled
based on answers to the 24-hour dietary recall and data
on the sodium content of foods [37].
We consulted the medical records of participants to
document causes of secondary osteoporosis (CSO: yes/
no), namely the use of certain medications in the last year
(corticosteroids, heparin, Dilantin, Prednisone, chemo-
therapy) or the diagnosis of diseases (Cushing’s disease,
rheumatoid arthritis, bone cancer, gastrectomy, kidney
failure, liver failure, thyroid and parathyroid diseases)
that may contribute to bone loss [38].
Physical activity (PA) was assessed using the short
form of the International Physical Activity Questionnaire
[39]. A dichotomous variable was created based on themedian value of the Total MET (metabolic equivalent)-
minutes/week, calculated using the algorithm in the
IPAQ document [39]. Values at or below the median
(3954 MET-minutes/week) define an inadequate level of
PA, or subjects considered inactive, while values above
the median define an adequate level of PA, or subjects
considered active.
Statistical analyses
Our database comprised 249 participants. DLC concentra-
tions were below the LOD (30 pg TCDD-EQ/L) for 16
participants. In these cases, we imputed a value between 0
and the LOD selected by simple random sampling with re-
placement. Of the 44 participants from the first commu-
nity visited, four had DL-PCB 105 concentrations below
the LOD, while one participant had a concentration of
DL-PCB 156 below the LOD (LOD = 0.02 μg/L). Plasma
concentrations of DL-PCBs 105, 118 and 156 below the
LOD (0.01 μg/L) were obtained in 45, 7 and 12 partici-
pants respectively among the 205 residents of the other
six communities. In these cases, we imputed a value equal
to LOD/2, that is, 0.01 μg/L for participants from the first
community and 0.005 μg/L for participants from the other
communities.
Descriptive statistics (mean, standard error, minimum
and maximum for quantitative variables; sample size
and % per modality for qualitative variables) of the
variables were generated for all participants.
The association between DLCs or each DL-PCB and
QUS parameters was examined by simple and multiple
linear regressions. Box-Cox procedures were used to
resolve problems encountered with the hypotheses of
normality and/or homoscedasticity in the multiple re-
gression models for the dependent variables SOS and SI,
which were subsequently log-transformed. Pearson’s
correlation coefficients were calculated between the
QUS parameters and the main exposure variables. The
confounding effect of different factors on the relation
between DLCs or DL-PCBs and QUS parameters was in-
vestigated. Secondary independent variables were tested
to determine whether or not they should be included in
the initial multiple regression models. Only those with a
p value ≤ 0.20 (in simple linear regression analysis) were
included. Multicollinearity between the variables of the
initial regression models was tested to ensure that vari-
ables were not redundant. To avoid multicollinearity
caused by the introduction of highly intercorrelated vari-
ables in the same linear regression model, we proposed
for each dependent variable (SOS, BUA and SI) separate
models that comprised only one of the main exposure
variables (either DLCs, DL-PCB 105, DL-PCB 118 or
DL-PCB 156). All potentially confounding variables were
entered in the multiple regression model and those that
did not change the value of β coefficient of the main
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by one, starting with the variable that accounted for the
least variation in the dependent variable. In the case of
highly intercorrelated anthropometric variables, when one
of these variables was not identified as a confounding
factor, and therefore not retained in the final model, the
initial model was rebuilt with the other variable.The final
adjustment of the models was for the total plasma lipid
concentration [40]. We also constructed a second set of
multivariate models (models II in Additional files 1, 2
and 3) adjusted for the same confounders and covariates.
A p value of < 0.05 in a bilateral situation is considered
statistically significant. The software used was SAS version
9.2 (SAS Institute Inc., Cary, NC, USA).
The project was approved by the Research Ethics
Committees of Université Laval and McGill University,
in partnership with McMaster University, and by the
Research Committee of the Cree Board of Health and
Social Services of James Bay. Participation in the study
was voluntary and a consent form was signed by each
participant. All information concerning the participants
was kept strictly confidential.
Results
With the weighting applied, the sample of 249 women (102
menopausal women and 147 non-menopausal women)
could be extrapolated to a population of 2056 women (883
menopausal women and 1173 non-menopausal women).
QUS parameters, plasma DLC and DL-PCB concen-
trations as well as selected characteristics of the Cree
women are shown in Table 1 and Additional file 4. Most
participants were non-menopausal, had a secondary level
education or higher, had had children, were sedentary,
non-smokers and did not drink alcohol. A small propor-
tion of women had used hormonal contraception or HRT,
had taken supplements (calcium and vitamin D) in the
12 months prior to the study and had a history of fracture
and conditions and/or medications identified as CSO.
Most of the Cree women (96.9%) had a waist circum-
ference ≥ 88 cm (abdominal obesity according to Health
Canada) [41]; the median value was 112 cm. With
respect to body mass index (BMI, kg/m2), according to
Health Canada criteria [41], only 3.5% of Cree women
had a normal BMI (between 18.5 and 24.9), 19.2% were
overweight (BMI between 25.0 and 29.9 kg/m2) and
77.3% were obese (BMI ≥ 30 kg/m2). Among Cree
women, 9.0% had a height of less than 153 cm, which
has been associated with osteoporosis [42].
The maximum blood lead level of 0.32 μmol/L noted
in women from the Quebec City area was exceeded by
26.9% of Cree women [43], while 14.2% exceeded
Canada’s alert level of 0.48 μmol/L [44].
With regard to blood mercury levels, 64.5% of Cree
women exceeded the maximum blood mercury level of16 nmol/L observed in women from the Quebec City
area [43], whereas 13.2% exceeded Canada’s alert level of
99.7 nmol/L [45].
Only 1.9% of participants exhibited a blood selenium
concentration exceeding the maximum level (3.6 μmol/
L) recorded in women from the Quebec City area [43]
and 1.8% showed a blood cadmium concentration over
the maximum value in the Quebec City inhabitants
(55 nmol/L) [43].
With respect to serum levels of vitamin D (25OHD),
2.3% of Cree women had a level considered as critical
(< 27.5 nmol/L) [46]; 14.6% displayed inadequate levels
(< 37.5 nmol/L), while 39.5% showed a level considered
minimal (< 50 nmol/L) [38].
Fasting glucose levels were considered normal (< 6.1
mmol/L) in 56.0% of Cree women, while 44.0% had
levels corresponding to hyperglycemia (≥ 6.1 mmol/L).
For 26.7% of Cree women, glucose levels could corres-
pond to type 2 diabetes (≥ 7.0 mmol/L) according to
the Canadian Diabetes Association [47].
Pearson’s r correlation coefficients revealed that QUS
parameters were negatively and significantly correlated
with DLCs, DL-PCBs and age, while the three DL-PCBs
were positively and significantly correlated with one
another and with age (see Additional file 5).
The final multivariate models of each QUS parameter,
constructed for each of the main exposure variables
(DLCs or DL-PCBs), are presented in Tables 2, 3 and 4.
DL-PCBs 105 and 118 were significantly and negatively
associated with SI (log); these associations persisted even
after adjustment for several confounding factors. Hence
the SI (log) decreased by −0.22% (p=0.0414) and −0.04%
(p=0.0483) for every one-unit increase (1 μg/L) in plasma
concentrations of DL-PCBs 105 and 118, respectively
(Table 4). In QUS parameters models built for each of the
main exposure variables and adjusted for the same factors
(see Additional files 1, 2 and 3, models II), DL-PCB 105
was negatively and significantly associated with BUA
(Additional file 2), whereas DL-PCBs 105 and 118 were
negatively and significantly associated with SI (log)
(Additional file 3).
Several variables were identified as confounders of
associations between exposure variables and QUS pa-
rameters. Some confounding factors were significantly
associated with SOS (log): age (in all models), level of
education (DLC, DL-PCB 105 and DL-PCB 118 models),
height (all DL-PCB models), PA (DL-PCB 105 and DL-
PCB 118 models), smoking status and menopausal status
(DL-PCB 105 model) (Table 2). In general, SOS (log) de-
creased with increasing age, height, menopausal status
and smoking status and SOS (log) increased with in-
creasing level of education and physical activity.
Age (in all models), level of education (DLC, DL-PCB
118 and DL-PCB 156 models) and % of omega-6 PUFAs
Table 1 Characteristics of participants
Characteristic N AM(a) ± SD(b) Range(c) GM(d) (95%-CI)(e)
Dependant variables
SOS (m/s) 249 1545.10 ± 39.21 1466.03-1665.22
BUA (dB/MHz) 249 118.05 ± 16.81 67.67-169.35
SI (%) 249 91.24 ± 20.59 46-151
Main exposition variables
DLC (pg TCDD-EQ/L) 249 234.13 ± 319.05 0.95-3115 124.31 (106.94-144.50)
DL-PCB 105 (μg/L) 249 0.09 ± 0.15 0.01-1.28 0.035 (0.03-0.04)
DL-PCB 118 (μg/L) 249 0.52 ± 0.90 0.01-8.35 0.19 (0.16-0.23)
DL-PCB 156 (μg/L)(f) 223 0.29 ± 0.42 0.01-3.15 0.12 (0.10-0.14)
Other variables
Age (years) 249 47.98 ± 10.72 35-74
Weight (kg) 248 91.46 ± 18.72 46.3-171.6
Lean mass (kg) 248 48.63 ± 6.48 25.8-75.2
Height (cm) 249 160.27 ± 6.03 134-175
Height in seated position (cm) 245 85.73 ± 3.24 74.7-93.85
Number of children 246 3.72 ± 2.77 0-13
Omega-3 PUFAs (%) 248 6.87 ± 1.38 2.16-13.9
Omega-6 PUFAs (%) 248 30.24 ± 1.73 22.44-33.76
Vitamin D (nmol/L) 249 59.03 ± 19.77 23-138
Glucose (mmol/L) 249 7.17 ± 8.98 3.0-21.8
Apolipoprotein B (g/L) 249 0.97 ± 1.17 0.31-2.62
Total lipid (g/L) 249 6.19 ± 1.28 3.49-14.64
Mercury (nmol/L) 249 51.09 ± 61.38 0.60-393.84 26.49 (22.67-30.94)
Selenium (μmol/L) 249 2.21 ± 0.42 1.3- 4.9 2.18 (2.14-2.23)
Lead (μmol/L) 249 0.29 ± 0.32 0.02-2.5 0.18 (0.16-0.21)
N N weighted (%)
Menopausal status 249 2056.13
Menopausal 102 882.589 (42.92)
Non-menopausal 147 1173.54 (57.08)
Level of education 248 2044.31
None or primary school 74 620.02 (30.33)
Secondary or higher 174 1424.29 (69.67)
Supplements use(g) 232 1881.49
Yes 39 272.365 (14.48)
No 193 1609.13 (85.52)
Physical activity 243 2021.47
Active 118 986.11 (48.78)
Inactive 125 1035.37 (51.22)
Tobacco use 248 2042.24
Yes 94 726.82 (35.59)
No 154 1315.43 (64.41)
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Table 1 Characteristics of participants (Continued)
Sodium intake 249 2056.13
≤ 2300 mg 108 876.94 (42.65)
> 2300 mg 141 1179.19 (57.35)
a Unweighted arithmetic mean.
b Standard deviation;
c Minimum-maximum;
d Unweighted geometric mean;
e 95%-Confidence interval of geometric mean;
f Variable not measured in one community;
g Calcium and vitamin D supplements.
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(Table 3). In general, BUA decreased with increasing age
and % of omega-6 PUFAs, and increased with increasing
level of education.
Lastly, age (in all models), level of education (DLC,
DL-PCB 118 and DL-PCB 156 models) and % of omega-
3 PUFAs (DL-PCB 118 model) were significantly associ-
ated with SI (Table 4). In general, SI (log) decreased with
increasing age, and increased with an increase in the
total % of omega-3 PUFAs and with increasing level of
education.
Discussion
This is the first population study to investigate the rela-
tionship between total DLC concentration measured
with an AhR responsive reporter gene assay and bone
quality parameters [48]. In Cree women aged 35 to
74 years of Eastern James Bay, DL-PCBs 105 and 118
were negatively and significantly associated with SI.
However, we did not find any association between total
DLC concentrations measured by the reporter gene bio-
assay and QUS parameters, which suggests that the effect
of PCBs is not linked to activation of the AhR signalling
pathway. Alternatively, the lack of association could also
be due to the lower precision of the bioassay measurement
compared to that of GC-MS measurements.
Three studies have been conducted on the relation be-
tween DL-PCBs and QUS bone parameters, with quite
controversial findings. In a group of Swedish men from
the general population (n = 115, age 40–75 years), Glynn
et al. [20] reported a positive association at the limit of
significance (β = 0.0044; p = 0.05) between serum concen-
trations of DL-PCB 167 and whole-body BMD (measured
by DXA), after adjustment for several confounding factors.
However, no association was observed between DL-PCB
167 and BUA or SOS parameters measured by ultrasound
at the left calcaneus [20]. No association was observed
between DL-PCBs 105, 118, 156 and QUS parameters or
lumbar spine, femoral neck or whole-body BMD [20].
Exploratory multivariate analyses conducted by Côté
et al. [21] revealed that plasma concentrations of DL-PCB
156 were negatively associated with QUS parameters mea-
sured in 153 peri- and postmenopausal Inuit women fromNuuk in Greenland (SOS model: β = −22.68, p = 0.014;
BUA model: β = −8.12, p = 0.028; SI model: β = −11.95,
p = 0.009) [21]. However, DL-PCBs 105 and 118 were
not associated with QUS parameters [21].
Hodgson et al. [22] found a negative association between
serum DL-PCB 118 concentration and forearm BMD
measured using DXA (β = −0.00024, p = 0.002) in the
dominant arm of 154 men (60–81 year old) from the
Swedish OSCAR cohort study. The odds ratio for low
BMD of 1.06 per 10 pg/mL DL-PCB 118 was significant
(95% CI: 1.01-1.12) [22]. However, in women (n = 167),
DL-PCB 118 was positively associated with BMD (β =
0.00008, p = 0.045). In this study, no association was
observed between DL-PCBs 105, 156, 157, 167 and
BMD; the authors considered the statistical power to
be limited and a large proportion of variance was not
explained by regression models [22].
In additional analyses, we performed logistic regression
using medians for SI (91%), DL-PCB 105 (0.03 μg/L) and
DL-PCB 118 (0.18 μg/L) as cut-off values between “low”
and “high” categories. Statistically-significant odds ratios
(OR) of 1.69 for low SI at high DL-PCB 105 exposure
(95% CI: 1.34-2.13) and 1.36 for low SI at high DL-PCB
118 exposure (95% CI: 1.06-1.73) were obtained in models
adjusted for all variables indicated in Table 4, confirming
the associations obtained by multiple linear regression.
However, the choice of medians as a cut-off values to de-
fine “low” and “high” categories of SI and the main expos-
ure variables is arbitrary and does not convey the same
meaning in different populations. Cut-off values for QUS
parameters based on pathophysiological considerations
are not available in the literature.
The geometric means (GMs) of plasma DL-PCB con-
centrations among Cree women were higher than those
reported in the 2007–2009 Canadian Health Measures
Survey for women aged 40 to 79 years and representa-
tive of the general Canadian population [49]. However,
mean plasma concentrations of DLCs in Cree women
estimated by the reporter gene assay were lower than those
of women of childbearing age (Inuit, Dene, Caucasian) in
other regions in Northern Canada [14].
Explanatory multivariate analyses revealed that several
other factors were significantly associated with QUS
Table 2 Results of explanatory multivariate analysis: SOS (log) models (I)
SOS (log) model Main exposure variable
DLCs (pg TCDD-EQ/L) DL-PCB 105 (μg/L) DL-PCB 118 (μg/L) DL-PCB 156 (μg/L)
N 240 220 241 202
R2 (Adjusted R2) 0.3086 (0.2721) 0.3470 (0.2990) 0.3070 (0.2737) 0.3123 (0.2725)
Regression coefficient (SE)(a) p-value Regression coefficient (SE)(a) p-value Regression coefficient (SE)(a) p-value Regression coefficient (SE)(a) p-value
Variables DLCs 0.4012 DL-PCB 105 0.2008 DL-PCB 118 0.1440 DL-PCB 156 0.2534
0.009 (0.01) −18.66 (14.54) −3.40 (2.32) −6.38 (5.57)
Age (years) −1.02 (0.30) 0.0007 −1.03 (0.29) 0.0005 −1.26 (0.19) <0.0001 −1.44 (0.22) <0.0001
Weight (kg) 0.007 (0.09) 0.9409 NR NR NR
Height (cm) −0.49 (0.28) 0.0852 −0.84 (0.28) 0.0027 −0.54 (0.27) 0.0466 −0.75 (0.29) 0.0118
Number of children NR 0.09 (0.63) 0.8854 NR −0.10 (0.61) 0.8749
Omega-3 PUFAs (%) 1.27 (1.27) 0.3176 2.19 (1.30) 0.0928 1.79 (1.28) 0.1620 2.11 (1.33) 0.1143
Vitamin D (nmol/L) NR 0.07 (0.10) 0.4498 NR NR
Mercury (nmol/L) 0.02 (0.03) 0.6270 0.03 (0.04) 0.4081 0.03 (0.03) 0.3461 0.05 (0.04) 0.2162
Selenium (μmol/L) 2.13 (3.86) 0.5820 0.39 (0.53) 0.4626 4.30 (3.70) 0.2463 2.74 (3.79) 0.4696
Glucose (mmol/L) NR 3.51 (3.64) 0.3354 0.46 (0.51) 0.3637 NR
Apolipoprotein B (g/L) −5.70 (3.90) 0.1454 NR −5.81 (3.86) 0.1340 NR
Menopausal status −8.62 (4.89) 0.0791 −10.34 (4.92) 0.0368 NR NR
Level of education 9.41 (3.86) 0.0156 10.15 (3.91) 0.0102 7.62 (3.84) 0.0486 8.06 (4.13) 0.0526
Smoking status NR −6.75 (3.39) 0.0480 NR −6.44 (3.59) 0.0741
Physical activity 5.49 (2.92) 0.0610 6.10 (3.03) 0.0454 5.97 (2.91) 0.0416 NR
Supplements use (b) NR −5.50 (4.82) 0.2550 NR −0.54 (5.19) 0.9177
Total lipid(c) (g/L) 0.51 (1.17) 0.6661 0.94 (1.27) 0.4582 0.47 (1.19) 0.6927 1.52 (1.33) 0.2532
a Regression coefficients and standard errors values are multiplied by 103;
b Calcium and vitamin D supplements;
c Final adjustment for the total plasma lipid concentration;















Table 3 Results of explanatory multivariate analysis: BUA models (I)
BUA model Main exposure variable
DLCs (pg TCDD-EQ/L) DL-PCB 105 (μg/L) DL-PCB 118 (μg/L) DL-PCB 156 (μg/L)
N 226 239 244 203
R2 (Adjusted R2) 0.3680 (0.3324) 0.3579 (0.3356) 0.3496 (0.3303) 0.3424 (0.3188)
Regression coefficient (SE) p-value Regression coefficient (SE) p-value Regression coefficient (SE) p-value Regression coefficient (SE) p-value
Variables DLCs 0.4275 DL-PCB 105 0.1060 DL-PCB 118 0.0841 DL-PCB 156 0.2649
0.005 (0.007) −13.23 (8.15) −2.42 (1.40) −3.79 (3.39)
Age (years) −0.73 (0.19) 0.0002 −0.78 (0.13) <0.0001 −0.83 (0.12) <0.0001 −0.74 (0.13) <0.0001
Weight (kg) 0.04 (0.06) 0.5404 NR NR NR
Lean mass (kg) NR 0.18 (0.17) 0.2924 NR NR
Height in seated position (cm) 0.19 (0.37) 0.6181 0.13 (0.36) 0.7163 NR NR
Omega-6 PUFAs (%) −1.43 (0.66) 0.0317 −0.72 (0.63) 0.2521 −0.75 (0.62) 0.2268 NR
Mercury (nmol/L) NR NR 0.01 (0.02) 0.4820 0.01 (0.02) 0.6159
Selenium (μmol/L) −1.998 (2.41) 0.4075 NR NR NR
Lead (μmol/L) 2.78 (3.66) 0.4487 NR NR NR
Number of children NR 0.42 (0.39) 0.2882 0.48 (0.38) 0.2144 0.43 (0.38) 0.2663
Menopausal status −2.63 (3.20) 0.4134 NR NR NR
Level of education 5.95 (2.43) 0.0150 4.63 (2.42) 0.0573 5.55 (2.37) 0.0202 5.28 (2.54) 0.0386
Supplements use(a) −3.58 (2.82) 0.2063 NR NR −2.53 (3.25) 0.4369
Sodium intake 2.56 (2.02) 0.2062 NR NR NR
Total lipid(b) (g/L) −0.93 (0.72) 0.1971 −0.02 (0.79) 0.9810 −0.24 (0.78) 0.7558 0.001 (0.83) 0.9991
a Calcium and vitamin D supplements;
b Final adjustment for the total plasma lipid concentration;















Table 4 Results of explanatory multivariate analysis: SI (log) models (I)
SI (log) model Main exposure variable
DLCs (pg TCDD-EQ/L) DL-PCB 105 (μg/L) DL-PCB 118 (μg/L) DL-PCB 156 (μg/L)
N 245 246 244 203
R2 (Adjusted R2) 0.3935 (0.3675) 0.3631 (0.3471) 0.3932 (0.3725) 0.3766 (0.3475)
Regression coefficient (SE)(a) p-value Regression coefficient (SE)(a) p-value Regression coefficient (SE)(a) p-value Regression coefficient (SE)(a) p-value
Variables DLCs 0.3806 DL-PCB 105 0.0414 DL-PCB 118 0.0483 DL-PCB 156 0.1379
0.07 (0.08) −219.24 (106.90) −37.84 (19.07) −69.81 (46.87)
Age (years) −13.87 (2.58) <0.0001 −12.74 (1.49) <0.0001 −12.55 (1.57) <0.0001 −12.21 (1.76) <0.0001
Weight (kg) 0.11 (0.75) 0.8815 NR NR NR
Height (cm) −2.09 (2.36) 0.3762 −0.75 (2.18) 0.7321 −2.38 (2.23) 0.2860 −2.60 (2.50) 0.2994
Number of children NR 6.22 (5.09) 0.2232 4.71 (5.00) 0.3477 25.2 (5.17) 0.6264
Omega-3 PUFAs (%) 18.36 (9.89) 0.0646 NR 23.90 (9.94) 0.0170 17.64 (11.36) 0.1221
Vitamin D (nmol/L) 0.57 (0.72) 0.4298 NR NR NR
Mercury (nmol/L) NR 0.22 (0.25) 0.3769 NR 0.31 (0.31) 0.3215
Glucose (mmol/L) NR NR 2.88 (4.18) 0.4914 NR
Menopausal status −26.05 (40.99) 0.5256 NR NR NR
Level of education 95.19 (31.70) 0.0030 NR 71.25 (31.37) 0.0240 72.72 (34.94) 0.0388
Smoking status −36.58 (27.40) 0.1831 NR NR NR
Supplements use(b) NR NR NR −12.67 (43.91) 0.7733
Total lipid(c) (g/L) −5.28 (9.51) 0.5796 7.31 (10.41) 0.4829 3.04 (10.38) 0.7696 7.19 (11.28) 0.5244
a Regression coefficients and standard errors values are multiplied by 103;
b Calcium and vitamin D supplements;
c Final adjustment for the total plasma lipid concentration;
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http://www.ehjournal.net/content/12/1/54parameters. Negative associations were found with age,
height, smoking status, menopausal status and omega-6
PUFAs, whereas positive associations were noted with
level of education, PA and % of omega-3 PUFAs.
Omega-3 PUFAs measured as a % of total fatty acids
in erythrocyte membrane phospholipids in Cree women
were positively and significantly associated with SI, while
the % of omega-6 PUFAs was negatively associated with
the BUA parameter. As observed following additional ana-
lyses, the omega-3/omega-6 PUFA ratio was positively and
significantly associated with BUA and SI (log). To our
knowledge, associations between omega-3 and omega-6
PUFAs and calcaneal QUS parameters have not been
reported previously. A high ratio of omega-6 to omega-3
PUFAs has been associated with low BMD [50], while a
higher dietary intake of omega-3 PUFAs had a protective
effect against bone loss [51,52].
Our study has several strengths. Firstly, the representa-
tiveness of our population sample was assured by the
recruitment strategy and the weighting scheme of the
study, which took non-response and refusal to participate
rates into account. Hence the findings can be generalized
to the entire female Cree population aged 35 to 74 years
living in Eastern James Bay communities. Secondly, we
took into consideration a large number of potential
confounding factors of the association between the main
exposure variables (DLCs, DL-PCBs) and QUS parame-
ters. Several of these factors were investigated for the first
time (% omega-3 and omega-6 PUFAs, mercury, selenium,
lead, glucose, apolipoprotein B). Thirdly, measurement
biases in the dependent variables or exposure variables are
relatively unlikely. Data collection in the field (ultrasound
measurements, anthropometric measurements, biological
samples) was performed by research nurses using stan-
dardized techniques. Completed questionnaires were
reviewed by members of the research team to ensure that
all the questions had been completely and properly an-
swered [30,31]. Individual levels of exposure to contami-
nants were measured using standardized methods in the
same laboratory (INSPQ) which has a quality control sys-
tem accredited according to ISO/CEI 17025, CAN-P-43
and ILAC G-13 standards. All laboratory analyses (plasma
or blood) were carried out, with two exceptions (PUFAs
and 25OHD), at the INSPQ laboratory. Measurement
accuracy complied with applicable standards.
Our study has also certain limitations. Firstly, the main
methodological limitation is its cross-sectional design,
with exposure and the dependent variable measured at
the same time (a single measurement for each subject),
such that the temporal sequence of cause and effect
cannot be determined. However, due to the fact that
DLCs and DL-PCBs accumulate in the body with age,
plasma concentrations in Cree women reflect their life-
long exposure. Secondly, the participation rate in thestudy varied largely between communities, which may
suggest a selection bias. However, this bias is quantita-
tively unimportant, since it is unlikely that the character-
istics of the subjects included in the study are different
from those of all eligible persons. The lists of beneficiar-
ies which were used to build the list of contact persons
were completed as necessary with information from
other local listings; moreover, the investigated communi-
ties are small and live in reserves, which facilitated the
identification and location of their members. Regarding
the non-response and refusal to participate in the study,
it is unlikely that these subjects have different levels of
plasma DL-PCBs congeners or QUS parameter values,
compared with participants; the recruitment of partici-
pants was made for a survey of general health and not spe-
cifically for the purpose of our study. Thirdly, the number
of participants with QUS measurements was relatively
small, limiting our capacity to observe an association be-
tween DLC concentrations determined by the reported
gene assay and QUS parameters, especially considering
that this measure is relatively imprecise compared to ana-
lytical chemistry based data. Fourthly, while we took a
maximum number of potential confounding factors
into account given the size of our sample, a residual
confounding effect cannot be ruled out. The determi-
nants of bone strength are multigenic and multifactorial
and other factors (genetic, nutritional, environmental) not
measured in our study could have decreased the residual
variance in multiple regression models. Lastly, two vari-
ables that are known to influence bone quality could not
be thoroughly assessed. The assessment of dietary calcium
intake considered only milk consumption. Physical activity
was evaluated using the short form of the IPAQ [39], an
instrument that proved difficult to administer in Cree
communities, even though its feasibility and validity has
been demonstrated in general populations (adults aged 15
to 69 years) of 12 countries [53]. Participants in our study
had trouble quantifying their activities, especially the du-
ration and intensity of activities during the week prior to
the study [54]. We believe that the proportion of active
Cree women was probably overestimated.
Conclusions
We observed negative associations between SI values and
plasma concentrations of two dioxin-like PCB congeners
in women from this Aboriginal population. Our study
does not allow causal inference and residual confounding
may still be present. Therefore, we do not believe that
dietary recommendations to reduce PCB exposure are
warranted at this time. In multivariate models, associa-
tions were also noted with dietary and lifestyle factors,
suggesting avenues to improve bone quality in this popu-
lation, such as smoking cessation and increases in
omega-3 PUFA intake and physical activity.
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